PROCOPE Medicals, designer of a new-generation artificial heart, starts preclinical trials in 2024 Nantes, April 15, 2024 – PROCOPE Medicals, a medtech born of a multidisciplinary encounter between engineers and cardiac surgeons, is designing a total artificial heart offering an innovative …

A heart transplant is an operation to replace a failing heart with a healthier donor heart. Heart transplantation is a treatment generally reserved for people whose condition has not improved sufficiently with medication or other surgical interventions. It is a …

Implantable medical devices are introduced into the human body through surgery or other medical interventions. Among the most common devices are artificial joints, breast implants, cochlear implants, intraocular lenses, pacemakers and other cardiac implants or prostheses. How do these implantable …

In recent years, technological advances in cardiology have opened up new treatment prospects for patients with serious heart problems. Nevertheless, these medical innovations do not solve all the challenges and complications that patients face on a daily basis. Today, Procope …

Heart transplantation is the reference treatment for patients suffering from severe heart failure, whose main challenge is to cope with the shortage of organs: “On average, there are two compatible recipient candidates for just one available heart graft”, explained Doctor …

Cardiovascular disease represents a major public health challenge, and it is imperative that we take a proactive approach to preserving the health of our hearts. There are many such conditions, making cardiovascular health awareness and prevention an important issue in …

There are different types of heart failure. It can be chronic (the disease sets in gradually, with symptoms worsening more slowly), or acute (the onset is rapid, or even sudden). There are also different stages of the disease, ranging from …

Procope Medicals is moving resolutely into 2024 with new milestones and key challenges in the design and development of its total artificial heart. Here’s an overview of what we’ll be talking about: Research and development (R&D) We are starting 2024 …

Heart failure is still responsible for 1 in 5 deaths. Once established, this cardiovascular disease is irreversible and worsens. “Life expectancy at 5 years is 50%” (according to Institut Pasteur Lille). It represents a major challenge for global healthcare systems. …

MedTech, at the crossroads of technology and healthcare, is shaping the development of medical devices with a relentless quest for innovation. In this dynamic landscape, several elements are redefining the design of these devices, with major implications for manufacturers. A …

Xenotransplantation is the process of transplanting living cells, organs or tissues from animals into humans. …

Remote Patient Monitoring (RPM) solutions can predict, prevent and manage events through continuous remote monitoring. …

The hemocompatibility (blood compatibility) of materials is a major issue in the design of medical devices, particularly artificial hearts. …

Studies show that women die at a systematically higher rate than men when waiting for a donor heart. …

Medtechs and Biotechs are positioning themselves as true drivers of medical innovation. This synergy between technology and medicine is fundamentally transforming the way healthcare is delivered. …

Nantes, France, June 6, 2023 - PROCOPE Medicals, designer of a fully implantable cardiac prosthesis, is proud to announce that it has already reached its minimum target of 400,000 euros in its fundraising campaign launched just 21 days ago. The fundraising is still underway and accessible on the Tudigo participative financing platform. …

In fact, there is as yet no destination therapy enabling patients to live with a heart prosthesis over the long term. …

The hemodynamics of the prosthesis are therefore analyzed by numerical simulation. This is an important part of our study on the biocompatibility and hemocompatibility of the prosthesis. …